Physician profile
David Bishop
NPI 1639606619
$5,680.81
in general payments reported to CMS, 2019-2025
35 companies · $892 in 2025
The $892 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $998 · 2021: $611 · 2022: $670 · 2023: $1,067 · 2024: $1,191 · 2025: $892.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,324 · Travel and Lodging: $827.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,323.52 |
| Travel and Lodging | $826.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,128.10 | 2023-2024 | |
| Rock Medical Orthopedics, INC. | $1,041.35 | 2020-2023 | |
| Horizon Therapeutics Plc | $545.73 | 2019-2023 | Krystexxa |
| Smith+Nephew, INC. | $395.29 | 2020-2025 | Grafix Pl, Stravix, Pico |
| Mimedx Group, INC. | $341.11 | 2024-2025 | |
| Integra Lifesciences Corporation | $330.81 | 2021-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Organogenesis INC. | $283.07 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $234.36 | 2022-2025 | Nuzyra |
| Kerecis Limited | $148.67 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Convatec INC. | $124.34 | 2019-2021 | |
| Nevro Corp. | $115.78 | 2023-2024 | Senza |
| Melinta Therapeutics, LLC | $108.37 | 2021 | |
| Polarityte, INC. | $106.46 | 2019 | |
| Stryker Corporation | $102.07 | 2023-2024 | Citrefix, Prostep, Easyfuse |
| Nexus Medical Technologies LLC | $95.55 | 2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $79.14 | 2024-2025 | Krystexxa |
| Polynovo North America LLC | $73.57 | 2024-2025 | Novosorb Btm |
| Vertex Pharmaceuticals Incorporated | $63.56 | 2025 | |
| Zimmer Biomet Holdings, INC. | $39.87 | 2020 | |
| Anika Therapeutics, INC. | $39.32 | 2021-2022 | |
| Abbott Laboratories | $29.50 | 2025 | Eterna |
| Trice Medical, INC. | $28.60 | 2021 | |
| Ani Pharmaceuticals, INC. | $24.92 | 2025 | Purified Cortrophin Gel |
| Lifenet Health | $21.44 | 2024 | Theragenesis Wound Matrix |
| Alfasigma USA, INC. | $20.99 | 2021 | |
| Treace Medical Concepts, INC. | $20.88 | 2022 | |
| Stimwave Technologies Incorporated | $20.28 | 2021 | |
| Ibsa Pharma INC. | $17.95 | 2023 | Tirosint, Licart |
| Acell, INC. | $16.56 | 2020 | |
| Aroa Biosurgery Incorporated | $15.61 | 2022 | |
| Bioventus LLC | $15.08 | 2022 | |
| Reapplix INC. | $14.56 | 2022 | |
| Ethicon US, LLC | $13.98 | 2022 | |
| Abbvie INC. | $11.97 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $11.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bishop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.